BioCopy
Latest round
- Series A
Last raised
- May 2026
Total raised
- $12M
Investors
- 1
About BioCopy
BioCopy AG, founded in 2016 and headquartered in Basel, Switzerland, focuses on biotherapeutics for cancer treatment.BioCopy specializes in next-generation biotherapeutics targeting cancer cells with unmatched specificity. The company's offerings include an automated antibody engineering platform that streamlines drug discovery via precision screening and extensive risk assessments, utilizing its ValidaTe technology.BioCopy's revenue model is based on B2B collaborations with biopharmaceutical companies and research institutions, engaging in licensing agreements and co-development deals. Revenue is generated when clients incorporate BioCopy’s products into their drug development pipelines, reflecting the complexity and value of the biotherapeutics developed. The company also has plans to expand its reach into new markets, specifically targeting additional regions in Europe and Asia by 2028, enhancing access to its innovative oncology solutions.
Who invested in BioCopy
1 investor across 1 round
See all investors in BioCopy
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 7, 2026
Amount
$12M
Investors
Questions about BioCopy
Who invested in BioCopy?
BioCopy has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioCopy raised?
BioCopy has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BioCopy last raise money?
BioCopy's most recent round on record is a Series A, in May 2026.
What does BioCopy do?
BioCopy AG, founded in 2016 and headquartered in Basel, Switzerland, focuses on biotherapeutics for cancer treatment.
Where is BioCopy headquartered?
BioCopy is headquartered in Basel, Switzerland.
Which VCs invest in companies like BioCopy?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at BioCopy's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like BioCopy? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.